Pentwater Capital Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Pentwater Capital Management’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-80,000	Closed	-$4.97M	–	144
2023 Q4	$4.97M	Buy	+80,000	New	+$1.99M	0.06%	70

Pentwater Capital Management's RYZB Position: Q1 2024 in Review

Pentwater Capital Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 80,000 shares — an estimated $4.97M sold.

Pentwater Capital Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $4.97M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Pentwater Capital Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Pentwater Capital Management sold 80,000 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $4.97M.
Pentwater Capital Management first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Pentwater Capital Management's RayzeBio, Inc. Common Stock position peaked at $4.97M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Pentwater Capital Management's 13F filing for Q1 2024, filed 15 May 2024.